RPID — Rapid Micro Biosystems Cashflow Statement
0.000.00%
Last trade - 00:00- $106.84m
- $87.63m
- $33.59m
Annual cashflow statement for Rapid Micro Biosystems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -73.5 | -60.8 | -52.5 | -46.9 | -47.1 |
| Depreciation | |||||
| Non-Cash Items | 25 | 4.75 | 3.73 | 4.14 | 6.75 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8 | -5.33 | 0.555 | -4.77 | 6.06 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -55 | -58.5 | -45.1 | -44.2 | -31.1 |
| Capital Expenditures | -3.22 | -6.74 | -1.84 | -1.36 | -0.85 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -10.1 | -86.7 | 44 | 38 | 15.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -13.3 | -93.5 | 42.2 | 36.7 | 14.3 |
| Financing Cash Flow Items | -1.34 | 0 | — | — | -1.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 217 | 0.693 | 0.149 | 0.203 | 19.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 148 | -151 | -2.78 | -7.29 | 3.04 |